Isagani (Gani) M. Chico, M.D.

VP and Global Head for Oncology

Fortrea

Talk to Gani about these topics and more:

Oncology clinical trials (early phase to post approval)
Oncology medical affairs
Pharmaceutical, academic and regulatory interactions

Biostatistics

Cell and Gene (CGT)

Clinical Data

Clinical Strategic Planning

Clinical Trial Retention

Clinical Trial Supply

Clinical Trial Technology

Clinical Trials

Communication Strategies

Contract Research Organization (CRO)

Corrective and preventive action (CAPA)

Decentralized Clinical Trials (DCTs)

Digital Health

Diversity

FDA

Healthcare

Licensing Strategies

M.D.

Patient Recruitment

Pharmacology 

Phase I/Early Phase Research 

Real-World Data

Regulatory

Research and Development

Research as Care

View Expert

John Doyle, DrPH

President, Consulting

Fortrea

Talk to John about these topics and more:

Tactics for driving health innovation
Optimizing market access strategies for new therapies
Demonstrating value through HEOR
Drug development life cycle strategies

View Expert

Tracy Parker

Vice President, Biometrics

Advanced Clinical

Talk to Tracy about these topics and more:

Biometrics services implementation 
Customer relationship and strategic portfolio management 
Ensuring successful and quality-driven delivery in mixed-model/hybrid engagements 
Navigating data management in complex trial designs 
Diversity considerations in clinical research

View Expert

Rebecca Starkie

Talk to Rebecca about these topics and more:

Voice of the patient
Patient engagement, recruitment, and retention
Working with patient advocacy groups
Diversity and health equality/equity in clinical research
Clinical research & project management

View Expert

Robin Marcus

Head of Global Decentralized Trials Market Development

Marken

Talk to Robin about these topics and more:

Optimizing and deploying patient-centric DCT services
Enhancing investigator site operations and reducing site burden
Ensuring high-quality biological sample collection and transport
Clinical research options for patient recruitment, adherence and retention
Strategies for addressing study challenges and recovering momentum

View Expert

Joan Chambers

Senior Consultant, Tufts Center for the Study of Drug Development

Talk to Joan about these topics and more:

Global Investigative Site Landscape
Decentralized Clinical Trial Solutions
Community Engagement for Clinical Trials
Collaborating with Patients and Patient Advocacy Groups for Clinical Trials
Clinical Research as a Care Option

View Expert